相关实验视频
Updated: Jan 12, 2026

09:15
Electrochemiluminescence Assays for Human Islet Autoantibodies
Published on: March 23, 2018
16.0K
对因克雷丁的自身抗体增加表明糖尿病患者的预后不佳
Minoru Takemoto1, Bo-Shi Zhang2, Aiko Hayashi3
1Department of Diabetes, Metabolism and Endocrinology, School of Medicine, International University of Health and Welfare, 4-3, Kozunomori, Narita, Chiba, 286-8686, Japan. minoru.takemoto@iuhw.ac.jp.
Scientific reports
|November 3, 2025
概括
在糖尿病患者中,抗胰岛素的自身抗体,例如依赖葡萄糖的胰岛素和类似葡萄糖的-1,较高. 这些因克雷丁自身抗体可能表明糖尿病管理的预后更差.
科学领域:
- 内分泌学 在内分泌学.
- 免疫学 免疫学 免疫学
- 代谢疾病 代谢疾病
背景情况:
- 胰岛素激素对葡萄糖平衡至关重要.
- 糖尿病中对自身免疫反应的对抗因克雷丁的反应尚不清楚.
研究的目的:
- 研究糖尿病患者对因克列激素自身抗体的临床意义.
- 探索因克列自身抗体作为预后生物标志物的潜力.
主要方法:
- 追溯队列研究包括274名糖尿病患者和109名健康对照.
- 测量针对依赖葡萄糖的胰岛素特异性 (GIP) 和类似葡萄糖的-1 (GLP-1) 的自身抗体,使用放大发光近距离同质试验相关的免疫吸收试验.
- 随访分析平均持续4.9年,以评估患者的预后.
主要成果:
- 与对照组相比,糖尿病患者的胰岛素自身抗体标位显著升高 (P < 0.01).
- GIP抗体阳性与明显更差的预后相关 (P = 0.0072).
- GLP-1抗体阳性显示出更差预后的趋势 (P = 0.06).
结论:
- 这项研究是首次报告糖尿病中对因克列激素的自身抗体.
- 升高的胰岛素自身抗体可能作为糖尿病的新型预后生物标志物.
- 这些发现支持进一步研究基于隐素的疗法和糖尿病的自身免疫机制.
相关概念视频
Diabetes Mellitus: Overview and Type I Subtype
4.8K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.8K
Dipeptidyl Peptidase 4 Inhibitors
574
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
574
Diabetes Mellitus: Type 2 and Gestational
4.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.3K
Glucagon-like Receptor Agonists
832
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
832
Pathophysiology of Diabetes
3.1K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.1K
Diabetes: Symptoms, Diagnosis, and Complications
2.0K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.0K

